Generics At the International Generic and Biosimilars Medicines Association (IGBA) meeting currently taking place in Lisbon, Portugal, in addition to international regulatory cooperation, several key studies were presented at the conference that highlight the need for a major overhaul of medicines policies to stimulate more access to generic, biosimilar and value added medicines. 16 June 2017